Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-01-28

FDA Approved: BUPROPION HYDROCHLORIDE — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved an original application for bupropion hydrochloride as a generic drug. The approval was issued to Rising Pharma Holdings, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupropion hydrochloride (Bupropion hydrochloride)

Snippet

ORIG AP for BUPROPION HYDROCHLORIDE (BUPROPION HYDROCHLORIDE)